Free Trial
ASX:IMR

Imricor Medical Systems (IMR) Stock Price, News & Analysis

Imricor Medical Systems logo

About Imricor Medical Systems Stock (ASX:IMR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
27,486 shs
Average Volume
N/A
Market Capitalization
$167.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. It also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Receive IMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

IMR Stock News Headlines

Imricor Commences VISABL-VT Trial
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Imricor Commences VISABL-VT Trial
See More Headlines

IMR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Imricor Medical Systems investors own include Frequency Therapeutics (FREQ), Cue Biopharma (CUE), Provention Bio (PRVB), Gold Standard Ventures (GSV), Nuwellis (CHFS), BCB Bancorp (BCBP) and Atomera (ATOM).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:IMR
CIK
N/A
Fax
N/A
Employees
140
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-20,260,000.00
Net Margins
-2,458.31%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$867,996.00
Price / Cash Flow
25.56
Book Value
A($0.03) per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$167.29 million
Optionable
Not Optionable
Beta
0.26
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (ASX:IMR) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners